This is the second indication granted by the FDA for Antizol and follows a 1997 approval for the treatment of confirmed or suspected ethylene glycol poisoning. Methanol is a common toxic chemical found in many household substances such as windshield wiper fluid and cleaning solutions. Methanol poisoning may cause severe morbidity, including blindness or death. Antizol was first approved as an antidote for ethylene glycol poisoning or for use in suspected ethylene glycol ingestion in December of 1997.
Ethylene glycol is the primary ingredient in antifreeze and other coolants.
The additional indication for Antizol supports our strategy in building strong brands in areas where there is a significant medical need. Orphan Medical acquires, develops, and markets pharmaceuticals of high medical value for inadequately treated and uncommon diseases. The information in this press release may contain forward-looking statements within the meaning of the Private Securities Litigation reform Act of 1995. A number of factors could cause actual results to differ materially from the Company's assumptions and expectations. All forward-looking statements are qualified by, and should be considered in conjunction with, such cautionary statements.